Exercise-induced activation of coagulation in subjects with activated protein C resistance

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 4, 2004, Pages 317-321

  Weiss, C ^a,c   Egermann, M ^a,b   Bartsch P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b AO RESEARCH INSTITUTE   (Switzerland)

^c Medizinische Klinik und Poliklinik V   (Germany)

Author keywords

Activated protein C resistance; Exercise; Fibrinopeptide A; Thrombin

Indexed keywords

ACTIVATED PROTEIN C; ANTIPLASMIN; ANTITHROMBIN III; D DIMER; FIBRIN; FIBRINOPEPTIDE A; MOLECULAR MARKER; OXYGEN; PROTHROMBIN; THROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ANALYTICAL ERROR; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPOTHESIS; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RUNNING; STANDARD; TIME;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TEST; FIBRINOLYSIS; HEMODYNAMIC PHENOMENA; HEMOSTASIS; HUMANS; MALE; THROMBOPHILIA;

EID: 2942594486     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200406000-00005     Document Type: Article

References (19)

1. Bourey RE, Santoro SA. Interactions of exercise, coagulation, platelets, and fibrinolysis - a brief review. Med Sci Sports Exerc 1988; 20:439-446.
2. Weiss C, Seitel G, Bärtsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998; 30:246-251.
3. Weiss C, Welsch B, Albert M, Friedmann B, Strobel G, Jost J, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998; 30:1205-1210.
4. Herren T, Bärtsch P, Haeberli A, Straub PW. Increased thrombin-antithrombin III complexes after 1 hour of physical exercise. J Appl Physiol 1992; 73:2499-2504.
5. Bärtsch P. Platelet activation with exercise and risk of cardiac events. Lancet 1999; 354:1747-1748.
6. Weiss C, Egermann M, Weiss T, Bärtsch P. Exercise-induced activation of coagulation in thrombophilia. J Thromb Haemost 2003; 1:1312-1313.
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
8. Stegmann H, Kindermann W, Schnabel A. Lactate kinetics and individual anaerobic threshold. Int J Sports Med 1981; 2:160-165.
9. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974; 37:247-248.
10. Haeberli A. Human protein data. Weinheim: VCH Verlagsgesellschaft, 1992, pp. XXV-XXVII.
11. Simioni P, Scarano L, Gavasso S, Sardella C, Girolami B, Scudeller A, Girolami A. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex levels in patients with inherited APC resistance due to factor V Leiden mutation. Br J Haematol 1996; 92:435-441.
12. Zoller B, Holm J, Svensson P, Dahlbäck B. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg 506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 1996; 75:270-274.
13. Lowe GD, Rumley A, Woodward M, Reid E, Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample-associations with cardiovascular risk factors and coagulation variables. Thromb Haemost 1999; 81:918-924.
14. Mannucci PM, Tripodi A, Bottasso B, Baudo F, Finazzi G, De Stefano V, et al. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost 1992; 67:200-202.
15. Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies - a crucial role for aquired free protein S deficiency. Thromb Haemost 1996; 76:190-194.
16. Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T. The risk of thrombosis in patients with lupus anticoagulants predicted by their specific coagulation profile. Thromb Haemost 1999; 81:695-700.
17. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999; 94:3702-3706.
18. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-1231.
19. Dahlbäck B. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 1999; 25:273-289.